Erythromycin resistance in Borrelia burgdorferi

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3637-3640

  Terekhova, Darya ^a   Sartakova, Marina L ^a   Wormser, Gary P ^a   Schwartz, Ira ^a   Cabello, Felipe C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; KINETICS; LYME DISEASE; MICROBIAL SENSITIVITY TESTS;

EID: 0036841155     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3637-3640.2002     Document Type: Article

References (19)

1. Cabello, F. C., M. L. Sartakova, and E. Y. Dobrikova. 2000. Genetic manipulation of spirochetes - light at the end of the tunnel. Trends Microbiol. 9:245-248.
2. Chambers, H. F. 2000. Protein synthesis inhibitors and miscellaneous antibacterial agents, p. 1239-1271. In J. G. Hardman, L. E. Limbird, and A. G. Gilman (ed.), Goodman & Gilman's the pharmacological basis of therapeutics, 10th ed. McGraw-Hill, New York, N.Y.
3. Dever, L. L., J. H. Jorgensen, and A. G. Barbour. 1993. Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. Antimicrob. Agents Chemother. 37:1704-1706.
4. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
5. Dykhuizen, D. E., and G. Baranton. 2001.The implications of a low rate of horizontal transfer in Borrelia. Trends Microbiol. 9:344-350.
6. Hardham, J. M., and E. L. Rosey. 2000. Antibiotic selective markers and spirochete genetics. J. Mol. Microbiol. Biotechnol. 2:425-432.
7. Johnson, R. C., C. B. Kodner, P. J. Jurkovich, and J. J. Collins. 1990. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete, Borrelia burgdorferi, to cefuroxime and other antimicrobial agents. Antimicrob. Agents Chemother. 34:2133-2136.
8. Johnson, R. C., C. Kodner, and M. Russell. 1987. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother. 31:164-167.
9. Johnson, R. C., C. Kodner, M. Russell, and D. Girard. 1990. In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin. J. Antimicrob. Chemother. 25(Suppl. A):33-38.
10. Liveris, D., S. Varde, R. Iyer, S. Koenig, S. Bittker, D. Cooper, D. McKenna, J. Nowakowski, R. B. Nadelman, G. P. Wormser, and I. Schwartz. 1999. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J. Clin. Microbiol. 37:565-569.
11. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria form virus sensitivity to virus resistance. Genetics 28:491-511.
12. Mursic, V. P., B. Wilske, G. Schierz, M. Holmburger, and E. Süß. 1987. In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur. J. Clin. Microbiol. 6:424-426.
13. Philipson, A. 1991. Antibiotic treatment in Lyme borreliosis. Scand. J. Infect. Dis. Suppl. 77:145-150.
14. Purser, J. E., and S. J. Norris. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 97:13865-13870.
15. Schwartz, J. J., A. Gazumyan, and I. Schwartz. 1992. rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi. J. Bacteriol. 174:3757-3765.
16. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
17. Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-740.
18. Weber, K. 1996. Treatment failure in erythema migrans-a review. Infection 24:73-75.
19. Wormser, G. P., R. B. Nadelman, R. J. Dattwyler, D. T. Dennis, E. D. Shapiro, A. C. Steere, T. J. Rush, D. W. Rahn, P. K. Coyle, D. H. Persing, D. Fish, and B. J. Luft. 2000. Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis. 31(Suppl. 1):S1-S14.